top of page
Executive Spotlights

BioMatrix Specialty Pharmacy Appoints Kathee Kramm as CEO in Strategic Leadership Transition

Plantation, FL, January 02, 2024 (PRNewswire) -- BioMatrix Specialty Pharmacy is pleased to announce the appointment of Kathee Kramm as Chief Executive Officer, succeeding the founder and former CEO, Nick Karalis. Kathee has been BioMatrix’s President and CEO after founding and leading AxelaCare Health Solutions. This significant transition follows a comprehensive year-long succession plan, poised to accelerate BioMatrix's expansion in the specialty infusion sector.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Comentarios


Life Science Headlines
bottom of page